Key result
Medical management remains the recommended initial strategy over PCI for stable Medina 001 bifurcation lesions.
Why the study?
The optimal management of bifurcation lesions remains debated, and an evidence-based approach to the uncommon Medina 001 lesion was needed.
This review outlines technical considerations and evidence-based interventional strategies for managing uncommon Medina 001 bifurcation lesions.
Supports initial medical management for stable lesions; leaves open need for randomized trials to guide PCI.
The optimal management of bifurcation lesions has received significant interest in recent years and remains a matter of debate among the interventional cardiology community. Bifurcation lesions are encountered in approximately 21% of percutaneous coronary intervention procedures and are associated with an increased risk of major adverse cardiac events. The Medina classification has been developed in an attempt to standardise the terminology when describing bifurcation lesions. The focus of this article is on the management of the Medina 0,0,1 lesion ('Medina 001'), an uncommon lesion encountered in <5% of all bifurcations. Technical considerations, management options and interventional techniques relating to the Medina 001 lesion are discussed. In addition, current published data supporting the various proposed interventional treatment strategies are examined in an attempt to delineate an evidence-based approach to this uncommon lesion.
No takes yet. Share an insight, caveat, or question.
Suleiman et al. (2021) conducted a review in Medina 001 bifurcation lesions (isolated ostial side branch disease). Percutaneous coronary intervention (PCI) and medical management was evaluated. Medical management is the recommended initial strategy for stable Medina 001 bifurcation lesions, with percutaneous coronary intervention reserved for acute coronary syndromes or refractory angina.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: